Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
Glioblastoma (GBM) is the most common malignant tumor of the central nervous system with poor prognosis. Although the field of immunotherapy in glioma is developing rapidly, glioblastoma is still prone to recurrence under strong immune intervention. The major challenges in the process of immunothera...
Guardado en:
Autores principales: | Yan Li, Yiqi Ma, Zijun Wu, Ruoxi Xie, Fanxin Zeng, Huawei Cai, Su Lui, Bin Song, Lei Chen, Min Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e99b2c58e79e464cb8394df395d9d8fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?
por: Vladislav O. Sarzhevskiy, et al.
Publicado: (2021) -
Identification of Differentially Expressed Genes in Different Glioblastoma Regions and Their Association with Cancer Stem Cell Development and Temozolomide Response
por: Justin Bo-Kai Hsu, et al.
Publicado: (2021) -
Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival
por: Peiyi Xie, et al.
Publicado: (2021) -
Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
por: Sudong Liu, et al.
Publicado: (2021) -
Towards Standardisation of Technique for En Bloc Sacrectomy for Locally Advanced and Recurrent Rectal Cancer
por: Ailín C. Rogers, et al.
Publicado: (2021)